More in this Section:

Interested in Participating?

 

If you think you meet the criteria for the REGN-COV2 trials and would like to enroll, please call the SMH Clinical Research Center at 941-917-2225 (open 8am-3pm, Monday-Friday).

Are You Eligible for COVID-19 Clinical Trials at SMH?

Sarasota Memorial is proud to be among the selected hospitals participating in several national and multi-national clinical research trials focused on preventing and treating SARS-CoV-2, the novel coronavirus that causes COVID-19. 

The SMH Clinical Research Team is currently enrolling eligible local participants for the following clinical trials: 

  • The study of Regeneron Pharmaceuticals' REGN-CoV-2 antibody cocktail for preventing COVID-19 in healthy adults.

  • The study of the REGN-CoV-2 antibody cocktail for treating COVID-19 in hospitalized and non-hospitalized adults.

  • Enrollment in these trials is time-sensitive and limited to those who meet specific eligibility criteria.

Want to help in the national search for ways to prevent and treat COVID-19? See criteria below to find out if you’re eligible.  

REGN-CoV2 for Preventing COVID-19 in Healthy Adults

Sarasota Memorial is now enrolling healthy adults in a clinical trial testing whether Regeneron Pharmaceuticals’ new REGN-COV2 dual-action antibody cocktail can prevent infection by SARS-CoV-2, the virus that causes COVID-19. This is a randomized, placebo-controlled, double-blind clinical trial. Click here to learn more about this trial.

Are You Eligible?

Are you a caregiver for a person infected with COVID-19? Do you live with someone currently sick with COVID-19 (SARS-CoV-2)? You may qualify, if:

  • You have been in recent close contact (typically residing in the same household) with a COVID-positive person. (Close contact must have been within 96 hours of receiving the REGN-CoV-2 antibody treatment or placebo.)

  • You have no symptoms of COVID-19 (fever, dry cough, shortness of breath, sore throat, etc.)

If you think you meet these criteria and would like to enroll in the prevention study, please call the SMH Clinical Research Center at 941-917-2225 (open 8am-3pm, Monday-Friday).

REGN-COV2 for Treating Adults with COVID-19 

Sarasota Memorial is participating in Phase 2/3 of the multi-national clinical trial testing Regeneron’s REGN-COV2 antibody cocktail in COVID-19 treatment. We are now enrolling both hospitalized patients with the novel coronavirus and those who have COVID-19 but aren’t sick enough to be hospitalized. 

This is a randomized, placebo-controlled, double-blind clinical trial. Participants will be randomly chosen to receive a single intravenous treatment (infusion) of either the antibody cocktail or a placebo. Click here to learn more about this trial.

Are You Eligible?

Have you recently experienced symptoms of COVID-19 (SARS-CoV-2)? If so, you may be able to participate, if:

  • You are at least 18 years old;

  • You have been tested for COVID-19 infection within the last 2 days (enrollment is time-sensitive; call even if results are still pending);

  • You have had one or more symptoms within the last 5 days (fever, dry cough, shortness of breath, sore throat, etc.).

If you think you meet these criteria and would like to enroll, please call the SMH Clinical Research Center at 941-917-2225 (open 8am-3pm, Monday-Friday).

Other COVID-19 Clinical Research at SMH

In early April, SMH began participating in two national clinical trials related to the treatment of COVID-19: testing the investigational antiviral drug remdesivir and evaluating the use of plasma donated by people who have recovered from COVID-19 to treat current SMH patients. Click here to learn more about these trials. 

Remdesivir: Following successful early trials, remdesivir is now commercially available under an emergency use order to treat severe COVID-19 cases. 

Convalescent Plasma: Along with trial partner SunCoast Blood Centers, Sarasota Memorial continues to study the use of donated plasma from those who have recovered from COVID-19 to treat patients currently hospitalized with severe cases of COVID-19. 

Are You Eligible to Donate Plasma?

Have you recovered from COVID-19? Your donated plasma could to help treat severely ill COVID-19 patients. We strongly encourage those who have had COVID-19 to contact SunCoast about making a plasma donation. You may be eligible to donate convalescent plasma, if:

  • You tested positive for or were diagnosed with COVID-19.

  • You have been symptom free for more than 14 days.

  • You meet current blood donation protocols.

If you think you meet these criteria and would like to donate convalescent plasma, please call SunCoast at 941-993-8119 or email covid19@suncoastblood.org.